<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1360099</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1360099</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis</article-title>
<alt-title alt-title-type="left-running-head">Scaricamazza et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1360099">10.3389/fphar.2024.1360099</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Scaricamazza</surname>
<given-names>Silvia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2691137/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Nesci</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2684725/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salvatori</surname>
<given-names>Illari</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2691149/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fenili</surname>
<given-names>Gianmarco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2621574/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosina</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/752435/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gloriani</surname>
<given-names>Michela</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2691302/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paronetto</surname>
<given-names>Maria Paola</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/583202/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madaro</surname>
<given-names>Luca</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/210162/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Ferri</surname>
<given-names>Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/361301/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Valle</surname>
<given-names>Cristiana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/754237/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>IRCCS Fondazione Santa Lucia</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Systems Medicine</institution>, <institution>University of Roma &#x201c;Tor Vergata&#x201d;</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Experimental Medicine</institution>, <institution>University of Roma &#x201c;La Sapienza&#x201d;</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Movement, Human and Health Sciences</institution>, <institution>University of Rome &#x201c;Foro Italico&#x201d;</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Neurology Unit</institution>, <institution>PTV Foundation Tor Vergata University Hospital</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Anatomy, Histology, Forensic Medicine and Orthopedics</institution>, <institution>University of Roma &#x201c;La Sapienza&#x201d;</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>National Research Council (CNR)</institution>, <institution>Institute of Translational Pharmacology (IFT)</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/56203/overview">Amira Zaky</ext-link>, Alexandria University, Egypt</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/423196/overview">Elena Bresciani</ext-link>, University of Milano-Bicocca, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/11537/overview">Alexandre Henriques</ext-link>, Neuro-Sys, France</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Cristiana Valle, <email>cristiana.valle@cnr.it</email>; Alberto Ferri, <email>alberto.ferri@cnr.it</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="equal" id="fn002">
<label>
<sup>&#x2021;</sup>
</label>
<p>These authors have contributed equally to this work and share last authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1360099</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Scaricamazza, Nesci, Salvatori, Fenili, Rosina, Gloriani, Paronetto, Madaro, Ferri and Valle.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Scaricamazza, Nesci, Salvatori, Fenili, Rosina, Gloriani, Paronetto, Madaro, Ferri and Valle</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background:</title>
<p>Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease characterized by the degeneration of motor neurons that leads to muscle wasting and atrophy. Epidemiological and experimental evidence suggests a causal relationship between ALS and physical activity (PA). However, the impact of PA on motor neuron loss and sarcopenia is still debated, probably because of the heterogeneity and intensities of the proposed exercises. With this study, we aimed to clarify the effect of intense endurance exercise on the onset and progression of ALS in the SOD1-G93A mouse model.</p>
</sec>
<sec>
<title>Methods:</title>
<p>We randomly selected four groups of twelve 35-day-old female mice. SOD1-G93A and WT mice underwent intense endurance training on a motorized treadmill for 8&#xa0;weeks, 5&#xa0;days a week. During the training, we measured muscle strength, weight, and motor skills and compared them with the corresponding sedentary groups to define the disease onset. At the end of the eighth week, we analyzed the skeletal muscle-motor neuron axis by histological and molecular techniques.</p>
</sec>
<sec>
<title>Results:</title>
<p>Intense endurance exercise anticipates the onset of the disease by 1&#xa0;week (age of the onset: trained SOD1-G93A &#x3d; 63.17 &#xb1; 2.25&#xa0;days old; sedentary SOD1-G93A &#x3d; 70.75 &#xb1; 2.45&#xa0;days old). In SOD1-G93A mice, intense endurance exercise hastens the muscular switch to a more oxidative phenotype and worsens the denervation process by dismantling neuromuscular junctions in the tibialis anterior, enhancing the Wallerian degeneration in the sciatic nerve, and promoting motor neuron loss in the spinal cord. The training exacerbates neuroinflammation, causing immune cell infiltration in the sciatic nerve and a faster activation of astrocytes and microglia in the spinal cord.</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>Intense endurance exercise, acting on skeletal muscles, worsens the pathological hallmarks of ALS, such as denervation and neuroinflammation, brings the onset forward, and accelerates the progression of the disease. Our findings show the potentiality of skeletal muscle as a target for both prognostic and therapeutic strategies; the preservation of skeletal muscle health by specific intervention could counteract the dying-back process and protect motor neurons from death. The physiological characteristics and accessibility of skeletal muscle further enhance its appeal as a therapeutic target.</p>
</sec>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<graphic xlink:href="FPHAR_fphar-2024-1360099_wc_abs.tif" position="anchor"/>
</p>
</abstract>
<kwd-group>
<kwd>amyotrophic lateral sclerosis</kwd>
<kwd>physical activity</kwd>
<kwd>endurance exercise</kwd>
<kwd>neurodegeneration</kwd>
<kwd>neuroinflammation</kwd>
<kwd>SOD1-G93A mice</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuropharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Amyotrophic lateral sclerosis (ALS) is an incurable disease characterized by the progressive loss of upper and lower motor neurons, which is just the tip of the iceberg of a chain of different and intertwined pathological events (<xref ref-type="bibr" rid="B22">Mead et al., 2023</xref>). For instance, the disruption of energy homeostasis has a strong impact on disease progression (<xref ref-type="bibr" rid="B11">Ferri and Coccurello, 2017</xref>; <xref ref-type="bibr" rid="B36">Steyn et al., 2018</xref>), as shown by ALS patients and animal models that share alterations in lipid and glucose metabolism and a defective energy balance with high energy expenditure and impaired ATP production (<xref ref-type="bibr" rid="B10">Dupuis et al., 2011</xref>; <xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>). Furthermore, the muscle fibers of ALS patients and animal models show poor metabolic flexibility and a propensity to use fatty acids as the main energy source (<xref ref-type="bibr" rid="B36">Steyn et al., 2018</xref>).</p>
<p>Physical activity (PA) is defined as any movement performed by skeletal muscles through energy consumption. Exercise resembles an organized scheme of PA that aims at improving or maintaining physical fitness through structured, planned, and repetitive movements (<xref ref-type="bibr" rid="B6">Dasso, 2019</xref>). Although exercise acts on the skeletal muscles, it indirectly influences the metabolism and physiology of the whole organism. Skeletal muscles respond to different stimuli by changing their metabolism and morphology through the differential expression of specific fiber types. For instance, different myosin heavy-chain isoforms allow specific contractility schemes (slow/fast), relying on a specific metabolic environment (<xref ref-type="bibr" rid="B25">Mukund, 2019</xref>). Consistently, skeletal muscle adaptations and changes in muscle-specific energy homeostasis could reflect on systemic metabolism (<xref ref-type="bibr" rid="B25">Mukund, 2019</xref>), thus representing a potential target for therapeutic approaches (<xref ref-type="bibr" rid="B8">Dupuis and Echaniz-Laguna, 2010</xref>; <xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>).</p>
<p>In ALS mouse models, the metabolic features of the skeletal muscle motor units more closely resemble the characteristics of long-lasting endurance exercise, even at resting state. The ALS muscle is mainly characterized by a glycolytic-to-oxidative switch of muscle fibers and a significant shift from the expression of myosin type IIb (MyHC IIb/MYH4) (characterizing fast glycolytic fibers) to myosin type IIa (MyHC IIa/MYH2) (marking fast oxidative fibers) (<xref ref-type="bibr" rid="B26">Peggion et al., 2017</xref>; <xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>). In a physio-pathological view, these metabolic modifications are not induced by an intense energy-demanding PA but are probably due to early mitochondrial dysfunctions that impair ATP production (<xref ref-type="bibr" rid="B9">Dupuis et al., 2004</xref>; <xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>).</p>
<p>The link between PA and ALS is still an open question. So far, the epidemiological studies have led to inconsistent results, probably because of the heterogeneity of PA analyzed, the difficulties in retrospective studies, and the variability in the onset and progression of ALS. Although several research studies describe PA as a risk factor for ALS, others do not report a significant correlation, and others even highlight its potential benefits for ALS patients (<xref ref-type="bibr" rid="B12">Ferri et al., 2019</xref>; <xref ref-type="bibr" rid="B5">Chapman et al., 2023</xref>). Furthermore, studies on mice trained with different exercise protocols have given inconsistent results depending on the type, duration, and intensity of the exercise (<xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>). Moreover, the importance of biological sex in influencing the onset and progression of the disease in response to endurance exercise was wildly highlighted in animal models of ALS, although these findings frequently present conflicting results (<xref ref-type="bibr" rid="B18">Kirkinezos et al., 2003</xref>; <xref ref-type="bibr" rid="B40">Veldink et al., 2003</xref>; <xref ref-type="bibr" rid="B21">Mahoney et al., 2004</xref>).</p>
<p>Herein, we dissect the effect of intense endurance exercise on female mice of the ALS mouse model SOD1-G93A by analyzing the <italic>in vivo</italic> functional readouts and the molecular alterations of the entire motor unit. To this aim, we trained mice for 8&#xa0;weeks on a motorized treadmill, starting before the onset of any ALS symptoms. We demonstrate that intense endurance training accelerates the onset and progression of the disease, fostering the oxidative status of skeletal muscles, inducing muscle denervation and motor neuron loss, and increasing central and peripheral neuroinflammation.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Animals</title>
<p>All animal procedures were carried out following the European guidelines for the use of animals in research (2010/63/EU) and the requirements of Italian laws (D.L. 26/2014); they were approved by the Italian Ministry of Health (protocol number 293/2021-PR).</p>
<p>Transgenic hemizygous SOD1-G93A male mice (B6.Cg-Tg [SOD1 <sup>G93A</sup>]1Gur/J) were obtained from The Jackson Laboratory (Bar Harbor, ME, United States of America; RRID:MGI:4835776) and then crossbred with C57BL/6 female mice to gain offspring. Generated animals were genotyped by PCR through hSOD1 oligos using interleukin-2 (IL-2) as a PCR internal control (sequences in <xref ref-type="table" rid="T1">Table 1</xref>). At the end of the training protocols, trained and untrained mice were anesthetized using Rompum (xylazine, 20&#xa0;mg mL<sup>&#x2212;1</sup>, 0.5 mL kg<sup>&#x2212;1</sup>, Bayer, Milan, Italy) in combination with Zoletil (tiletamine and zolazepam, 100&#xa0;mg mL<sup>&#x2212;1</sup>, 0.5 mL kg<sup>&#x2212;1</sup>, Virbac, Milan, Italy). After the pedal-withdrawal reflex was no longer present, the mice were euthanized for tissue dissection.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Target genes and primer sequences used for real-time PCR.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Accession number</th>
<th align="center">Target</th>
<th align="center">Forward sequence</th>
<th align="center">Reverse sequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">NM_000454</td>
<td align="center">Sod1</td>
<td align="center">5&#x2032;-CAT&#x200b;CAG&#x200b;CCC&#x200b;TAA&#x200b;TCC&#x200b;ATC&#x200b;TGA-3&#x2032;</td>
<td align="center">5&#x2032;-CGC&#x200b;GAC&#x200b;TAA&#x200b;CAA&#x200b;TCA&#x200b;AAG&#x200b;TGA-3&#x2032;</td>
</tr>
<tr>
<td align="center">AF195955</td>
<td align="center">Il-2</td>
<td align="center">5&#x2032;-TAG&#x200b;GCC&#x200b;ACA&#x200b;GAA&#x200b;TTG&#x200b;AAA&#x200b;GAT&#x200b;CT-3&#x2032;</td>
<td align="center">5&#x2032;-GTA&#x200b;GGT&#x200b;GGA&#x200b;AAT&#x200b;TCT&#x200b;AGC&#x200b;ATC&#x200b;ATC C-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_001307989</td>
<td align="center">Nor1</td>
<td align="center">5&#x2032;-TAC&#x200b;GCC&#x200b;ACG&#x200b;CAG&#x200b;ACT&#x200b;TAT&#x200b;GG-3&#x2032;</td>
<td align="center">5&#x2032;-TGG&#x200b;TCA&#x200b;GCT&#x200b;TGG&#x200b;TGT&#x200b;AGT&#x200b;CG-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_025540</td>
<td align="center">Sln</td>
<td align="center">5&#x2032;-TGA&#x200b;GGT&#x200b;CCT&#x200b;TGG&#x200b;TAG&#x200b;CCT&#x200b;GA-3&#x2032;</td>
<td align="center">5&#x2032;-CAC&#x200b;ACC&#x200b;AAG&#x200b;GCT&#x200b;TGT&#x200b;CTT&#x200b;CA-3&#x2032;</td>
</tr>
<tr>
<td align="center">AB008453</td>
<td align="center">Glut4</td>
<td align="center">5&#x2032;-GGT&#x200b;GTG&#x200b;GTC&#x200b;AAT&#x200b;ACG&#x200b;GTC&#x200b;TTC&#x200b;AC-3&#x2032;</td>
<td align="center">5&#x2032;-AGC&#x200b;AGA&#x200b;GCC&#x200b;ACG&#x200b;GTC&#x200b;ATC&#x200b;AAG&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_001039545</td>
<td align="center">Myhc IIa</td>
<td align="center">5&#x2032;-AGT&#x200b;CCC&#x200b;AGG&#x200b;TCA&#x200b;ACA&#x200b;AGC&#x200b;TG-3&#x2032;</td>
<td align="center">5&#x2032;- GCA&#x200b;TGA&#x200b;CCA&#x200b;AAG&#x200b;GTT&#x200b;TCA&#x200b;CA-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_010855</td>
<td align="center">Myhc IIb</td>
<td align="center">5&#x2032;-AGT&#x200b;CCC&#x200b;AGG&#x200b;TCA&#x200b;ACA&#x200b;AGC&#x200b;TG-3&#x2032;</td>
<td align="center">5&#x2032;-TTT&#x200b;CTC&#x200b;CTG&#x200b;TCA&#x200b;CCT&#x200b;CTC&#x200b;AAC&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_009930</td>
<td align="center">Col3a1</td>
<td align="center">5&#x2032;-CCC&#x200b;AAC&#x200b;CCA&#x200b;GAG&#x200b;ATC&#x200b;CCA&#x200b;TT-3&#x2032;</td>
<td align="center">5&#x2032;-GGT&#x200b;CAC&#x200b;CAT&#x200b;TTC&#x200b;TCC&#x200b;CAG&#x200b;GA-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_026346</td>
<td align="center">Atrogin-1</td>
<td align="center">5&#x2032;-TGA&#x200b;GCG&#x200b;ACC&#x200b;TCA&#x200b;GCA&#x200b;GTT&#x200b;AC-3&#x2032;</td>
<td align="center">5&#x2032;-GCG&#x200b;CTC&#x200b;CTT&#x200b;CGT&#x200b;ACT&#x200b;TCC&#x200b;TT-3&#x2032;</td>
</tr>
<tr>
<td align="center">AF325348</td>
<td align="center">Achr&#x3b1;</td>
<td align="center">5&#x2032;-GGC&#x200b;TTT&#x200b;CAC&#x200b;TCT&#x200b;CCG&#x200b;CTG&#x200b;AT-3&#x2032;</td>
<td align="center">5&#x2032;-TCA&#x200b;GCG&#x200b;GCG&#x200b;TTA&#x200b;TTG&#x200b;GAC&#x200b;TC-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_021544</td>
<td align="center">Na<sub>v</sub>1.5</td>
<td align="center">5&#x2032;-AGA&#x200b;TGT&#x200b;CTC&#x200b;CCC&#x200b;CAG&#x200b;TAA&#x200b;CCA-3&#x2032;</td>
<td align="center">5&#x2032;-CTT&#x200b;GGG&#x200b;GAG&#x200b;CCT&#x200b;GTC&#x200b;TCT&#x200b;C-3&#x2032;</td>
</tr>
<tr>
<td align="center">NM_013684</td>
<td align="center">Tata box-binding protein</td>
<td align="center">5&#x2032;-CCA&#x200b;ATG&#x200b;ACT&#x200b;CCT&#x200b;ATG&#x200b;ACC&#x200b;CCT&#x200b;A-3&#x2032;</td>
<td align="center">5&#x2032;-CAG&#x200b;CCA&#x200b;AGA&#x200b;TTC&#x200b;ACG&#x200b;GTA&#x200b;GAT-3&#x2032;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-2">
<title>2.2 Exercise training protocol</title>
<p>Female SOD1-G93A and WT littermate mice were randomly categorized into an intense endurance training group and a sedentary control group (n &#x3d; 12/group). At 35 days of age, mice started running on a motorized treadmill (Ugo Basile, Rodent Treadmill NG cat. 47300) five times a week for 8&#xa0;weeks, increasing speed, uphill slope, and time as shown in <xref ref-type="table" rid="T2">Table 2</xref>; we modified the protocol from <xref ref-type="bibr" rid="B1">Alizadeh et al. (2015)</xref> to obtain an intense endurance exercise. The treadmill was equipped with a mild shock to encourage the animal to keep running.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Intense endurance exercise protocol on motor treadmill modified from the work of <xref ref-type="bibr" rid="B1">Alizadeh et al. (2015)</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Weeks of training</th>
<th align="center">Parameter</th>
<th align="center">Monday</th>
<th align="center">Tuesday</th>
<th align="center">Wednesday</th>
<th align="center">Thursday</th>
<th align="center">Friday</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="center">
<bold>1st week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">5</td>
<td align="center">5</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>2nd week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">30</td>
<td align="center">30</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>3rd week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">30</td>
<td align="center">30</td>
<td align="center">30</td>
<td align="center">45</td>
<td align="center">45</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>4th week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">13</td>
<td align="center">13</td>
<td align="center">13</td>
<td align="center">13</td>
<td align="center">13</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">45</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>5th week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">17</td>
<td align="center">17</td>
<td align="center">17</td>
<td align="center">17</td>
<td align="center">17</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>6th week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">19</td>
<td align="center">19</td>
<td align="center">19</td>
<td align="center">19</td>
<td align="center">19</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>7th week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
</tr>
<tr>
<td rowspan="3" align="center">
<bold>8th week</bold>
</td>
<td align="left">Speed (meters/minute)</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
<td align="center">22</td>
</tr>
<tr>
<td align="left">Slope (degree)</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">Time (minutes)</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
<td align="center">60</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>To reduce animal stress and experimental variability, the training was carried out in the morning between 8:00 a.m. and 1:00 p.m., and it included, on top of the training, 1&#xa0;hour of acclimatization in the experimental room, 10&#xa0;min of warm-up, and 10&#xa0;min of cool-down.</p>
<p>The day after the last training section, trained and sedentary mice were anesthetized and euthanized, and the tissues were collected.</p>
</sec>
<sec id="s2-3">
<title>2.3 Disease progression evaluation</title>
<p>The disease progression was evaluated starting from 35 days of age (i.e., the start of the training) until the end of the training period (91 days of age) by measuring weight and grip strength and scoring the motor skills.</p>
<sec id="s2-3-1">
<title>2.3.1 Weight</title>
<p>Body weight was measured twice a week before the training session and other tests.</p>
</sec>
<sec id="s2-3-2">
<title>2.3.2 Grip strength by the grid net</title>
<p>The test consisted of three attempts per mouse with a resting time of 1&#xa0;minute between every attempt; the mean of the three examinations, representing the strength of four limbs, was normalized to the weight of the mouse as previously described (<xref ref-type="bibr" rid="B30">Scaricamazza et al., 2022</xref>). The test was carried out by the same operator to minimize experimental variability.</p>
</sec>
<sec id="s2-3-3">
<title>2.3.3 Motor skills</title>
<p>Following <xref ref-type="bibr" rid="B24">Milanese et al.&#x2019;s (2021)</xref> testing of the hind limb extension reflex, we assessed the hind limb posture and extension while holding the animal suspended by the tail (<xref ref-type="bibr" rid="B24">Milanese et al., 2021</xref>). To assess the gait, the mice were allowed to walk freely in an open field, and we assigned a score to their motor deficits by observing them (<xref ref-type="bibr" rid="B24">Milanese et al., 2021</xref>). The scoring scale ranged from a maximum of 5 points (no motor dysfunctions) to 0 (complete impairment), as shown in <xref ref-type="table" rid="T3">Table 3</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Score scale to evaluate the hind limb extension reflex and gait impairment, modified from the work of <xref ref-type="bibr" rid="B24">Milanese et al. (2021)</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="center">Hind limb extension reflex</th>
<th colspan="2" align="center">Gait</th>
</tr>
<tr>
<th align="center">Score</th>
<th align="center">Description</th>
<th align="center">Score</th>
<th align="center">Description</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">
<bold>5</bold>
</td>
<td align="left">Normal functions</td>
<td align="center">
<bold>5</bold>
</td>
<td align="left">Normal functions</td>
</tr>
<tr>
<td align="center">
<bold>4.75</bold>
</td>
<td align="left">Slight and transient limb extension deficits</td>
<td align="center">
<bold>4.75</bold>
</td>
<td align="left">Slight and transient stagger gait</td>
</tr>
<tr>
<td align="center">
<bold>4.5</bold>
</td>
<td align="left">Slight extension deficits and the symmetry of the hind limbs</td>
<td align="center">
<bold>4.5</bold>
</td>
<td align="left">Slight stagger gait at the rear torso</td>
</tr>
<tr>
<td align="center">
<bold>4</bold>
</td>
<td align="left">Slight extension deficits and slight signs of hind limb asymmetry</td>
<td align="center">
<bold>4</bold>
</td>
<td align="left">Moderate stagger gait at the rear torso and straight and fast gait</td>
</tr>
<tr>
<td align="center">
<bold>3.5</bold>
</td>
<td align="left">Moderate extension reflex deficits or moderate signs of hind limb asymmetry: possible slight tremors</td>
<td align="center">
<bold>3.5</bold>
</td>
<td align="left">Slight motor deficits of one or both hind limbs and straight gait</td>
</tr>
<tr>
<td align="center">
<bold>3</bold>
</td>
<td align="left">Moderate extension reflex deficits and/or moderate signs of hind limb asymmetry: possible moderate tremors</td>
<td align="center">
<bold>3</bold>
</td>
<td align="left">Moderate motor deficits of one or both hind limbs and slow straight gait</td>
</tr>
<tr>
<td align="center">
<bold>2.5</bold>
</td>
<td align="left">Severe extension reflex deficits, stretching and stiffness of one of both hind limbs, slight signs of paralysis for one of both hind limbs, possible severe tremors</td>
<td align="center">
<bold>2.5</bold>
</td>
<td align="left">Stiffness of one or both hind limbs, loose gait, and possible dragging tail</td>
</tr>
<tr>
<td align="center">
<bold>2</bold>
</td>
<td align="left">Slight paralysis of one or both hind limbs, contraction, or unnaturally stretching and possible slight signs of spine arching</td>
<td align="center">
<bold>2</bold>
</td>
<td align="left">Severe motor deficits due to slight paralysis of one or both hind limbs, gait mainly using the forelimbs, possible dragging tail, and possible signs of spine arching</td>
</tr>
<tr>
<td align="center">
<bold>1.5</bold>
</td>
<td align="left">Moderate paralysis of one or both hind limbs, contraction, or unnatural stretching and possible moderate signs spine arching</td>
<td align="center">
<bold>1.5</bold>
</td>
<td align="left">Severe motor deficits due to moderate paralysis of one or both hind limbs, gait only using the forelimbs, dragging tail, and possible moderate signs of spine arching</td>
</tr>
<tr>
<td align="center">
<bold>1</bold>
</td>
<td align="left">Severe paralysis of both hind limbs, contraction or unnaturally stretching, and slight hind limb movement only when touched and possible severe arching of the spine</td>
<td align="center">
<bold>1</bold>
</td>
<td align="left">The animal drags itself using the forelimbs only; dragging tail; and spine arching</td>
</tr>
<tr>
<td align="center">
<bold>0.5</bold>
</td>
<td align="left">Complete paralysis of both hind limbs and humane end-point score for euthanasia</td>
<td align="center">
<bold>0.5</bold>
</td>
<td align="left">Very limited circular movements, signs of impairment of forelimbs, and humane end-point score for euthanasia</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The bold values represent the scores blindly assign for the motor skills (extension of the hindlimb and the gait). The score goes from 5 (no motor dysfunctions) to 0 (complete motor dysfunctions), modified from <xref ref-type="bibr" rid="B24">Milanese et al. (2021)</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-3-4">
<title>2.3.4 Onset</title>
<p>The onset of ALS in SOD1-G93A mice was defined by considering weight, grip strength, and motor skills together using a score method ranging from 0 to 9 (0 &#x3d; no impairments in any category; 9 &#x3d; impairments in all categories). Specifically, we assigned 1 to weight when the weight of SOD1-G93A mice was 20% lower than the mean weight of WT mice. We assigned 1 to grip strength when SOD1-G93A mice had a muscular strength reduction of 20%. We assigned 1 to the extension reflex of the hind limb and 1 to the gait when SOD1-G93A mice reached a score of 4.75.</p>
<p>While the grip strength and the weight are two quantitative tests, the motor skill tests are qualitative tests where the score is given by the operator. Even though the evaluation is blind, to avoid biases, we decide to multiply the weight and grip strength scores by 3 and the extension reflex of the hind limb and the gait scores by 1.5; then, we define that the disease had started when, by adding up the points of every category, the mouse reached a total score of 6. Finally, we represented the onset with a Kaplan&#x2013;Meier graph.</p>
</sec>
</sec>
<sec id="s2-4">
<title>2.4 RNA isolation and real-time qPCR</title>
<p>Total RNA was obtained from the tibialis anterior (TA) of 91-day-old trained and sedentary SOD1-G93A and WT mice (n &#x2265; 5 for each experimental group) with TRIzol<sup>&#xae;</sup> Reagent (Ambion, Life Technologies) and reverse-transcribed using the ImProm-II&#x2122; Reverse Transcription System (Promega). Real-time qPCR was used to evaluate the levels of mRNA expression with a LightCycler 480 SYBR Green System (Roche, ETC). We used the &#x201c;second derivative max&#x201d; algorithm of the LightCycler software to calculate the crossing point (Cp) values. We chose the TATA box-binding protein as the housekeeping gene for normalization. Primer sequences are listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</sec>
<sec id="s2-5">
<title>2.5 Electrophoresis and Western blotting</title>
<p>Protein samples, obtained from the TA of sedentary and trained 91-day-old SOD1-G93A and WT littermate mice (n &#x2265; 5 for each experimental group), were separated by SDS&#x2013;PAGE and transferred onto nitrocellulose membranes (PerkinElmer, Cat&#x23; NBA085B). The membranes were blocked with 5% milk, incubated with the appropriate primary antibodies (<xref ref-type="table" rid="T4">Table 4</xref>), incubated with the appropriate peroxidase-conjugated secondary antibodies (<xref ref-type="table" rid="T4">Table 4</xref>), and developed using enhanced chemiluminescence (Bio-Rad Clarity<sup>TM</sup> Western ECL Substrate, Cat&#x23; 170&#x2013;5061. Densitometric analyses were performed using ImageJ software (U.S. National Institutes of Health, Bethesda, Maryland, United States of America, <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>), and we analyzed five samples per group, divided into two different blots. The expression of proteins of interest was normalized to GAPDH expression levels.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Primary and secondary antibodies used for Western blot and IF assays.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="right"/>
<th align="left">Antibody</th>
<th align="left">Product</th>
<th align="left">Dilution</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="12" align="left">Primary</td>
<td align="left">Myosin heavy chain, type 2B BF-F3</td>
<td align="left">DSHB</td>
<td align="left">IF 1:50</td>
</tr>
<tr>
<td align="left">Myosin heavy chain, type 2A 2F7</td>
<td align="left">DSHB</td>
<td align="left">IF 1:10</td>
</tr>
<tr>
<td align="left">Laminin</td>
<td align="left">Sigma-Aldrich (Cat&#x23;L9393)</td>
<td align="left">IF 1:500</td>
</tr>
<tr>
<td align="left">ATPB</td>
<td align="left">Abcam (Cat&#x23;ab14730)</td>
<td align="left">IF 1:500</td>
</tr>
<tr>
<td align="left">Synaptophysin</td>
<td align="left">Thermo Fisher Scientific (Cat&#x23;MA1-34660)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">NFH</td>
<td align="left">BioLegend (Cat&#x23;836001)</td>
<td align="left">IF 1:1,000</td>
</tr>
<tr>
<td align="left">MBP</td>
<td align="left">Cell Signaling Technology (Cat&#x23;78896)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">CD68</td>
<td align="left">Bio-Rad/AbD Serotec (Cat&#x23;MCA1957GA)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">GFAP</td>
<td align="left">Novus Biological (Cat&#x23;NBP1-05197)</td>
<td align="left">IF 1:500</td>
</tr>
<tr>
<td align="left">LRP4</td>
<td align="left">BioLegend (Cat&#x23;832201)</td>
<td align="left">WB 1:1,000</td>
</tr>
<tr>
<td align="left">Dystrophin</td>
<td align="left">Proteintech (Cat&#x23;12715-1-AP)</td>
<td align="left">WB 1:2000</td>
</tr>
<tr>
<td align="left">GAPDH</td>
<td align="left">Santa Cruz Biotechnology (Cat&#x23;sc-20356)</td>
<td align="left">WB 1:10,000</td>
</tr>
<tr>
<td rowspan="10" align="left">Secondary</td>
<td align="left">Goat anti-mouse IgM (heavy chain) cross-adsorbed secondary antibody, Alexa Fluor&#x2122; 555</td>
<td align="left">Thermo Fisher (Cat&#x23;A-21426)</td>
<td align="left">IF 1:400</td>
</tr>
<tr>
<td align="left">Goat anti-mouse IgG1 cross-adsorbed secondary antibody, Alexa Fluor&#x2122; 488</td>
<td align="left">Thermo Fisher (Cat&#x23;A-21121)</td>
<td align="left">IF 1:400</td>
</tr>
<tr>
<td align="left">Alexa Fluor<sup>&#xae;</sup> 488 AffiniPure Donkey Anti-Rabbit IgG (H &#x2b; L)</td>
<td align="left">Jackson ImmunoResearch Laboratories (Cat&#x23;711-545-152)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">Cy&#x2122;3 AffiniPure F(ab&#x27;)&#x2082; Fragment Donkey Anti-Mouse IgG (H &#x2b; L)</td>
<td align="left">Jackson ImmunoResearch Laboratories (Cat&#x23;715-166-150)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">&#x391;-Bungarotoxin Alexa Fluor 594 Conjugate</td>
<td align="left">Invitrogen&#x2122; (Cat&#x23;B13423)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">Cy&#x2122;5 AffiniPure F(ab&#x27;)&#x2082; Fragment Donkey Anti-Rabbit IgG (H &#x2b; L)</td>
<td align="left">Jackson ImmunoResearch Laboratories (Cat&#x23;711-175-152</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">Cy&#x2122;3 AffiniPure F(ab&#x27;)&#x2082; Fragment Donkey Anti-Mouse IgG (H &#x2b; L)</td>
<td align="left">Jackson ImmunoResearch Laboratories (Cat&#x23;715-166-150)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">Alexa Fluor<sup>&#xae;</sup> 488 AffiniPure Donkey Anti-Rat IgG (H &#x2b; L)</td>
<td align="left">Thermo Fisher Scientific (Cat&#x23;A-21208)</td>
<td align="left">IF 1:200</td>
</tr>
<tr>
<td align="left">Goat Anti-Rabbit IgG (H &#x2b; L)-HRP Conjugate</td>
<td align="left">Bio-Rad Laboratories (Cat&#x23;1706515)</td>
<td align="left">WB 1:2500</td>
</tr>
<tr>
<td align="left">Goat Anti-Mouse IgG (H &#x2b; L)-HRP Conjugate</td>
<td align="left">Bio-Rad Laboratories (Cat&#x23;170-6516)</td>
<td align="left">WB 1:2500</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>WB: Western blot.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-6">
<title>2.6 Skeletal muscle immunofluorescence and histochemistry</title>
<p>The TA of 91-day-old trained and sedentary SOD1-G93A and WT mice (n &#x2265; 5 for each experimental group) was embedded into the Tissue-Tek Optimal Cutting Temperature (O.C.T.) Compound and sectioned at 10&#xa0;&#x3bc;m using a Leica Cryostat.</p>
<p>For nicotinamide adenine dinucleotide dehydrogenase (NADH)-tetrazolium reductase activity staining, TA cryosections were hydrated in 0.1&#xa0;M Tris-HCl, pH 7.5, for 10&#xa0;min and incubated in NADH-tetrazolium reductase activity solution (0.4&#xa0;mg/mL NADH, 0.8&#xa0;mg/mL NTB, and 1&#xa0;M Tris-HCl, pH 7.5) for 40&#xa0;min at 37&#xb0;C in a humidified chamber. The slides were dehydrated in increasing concentrations of ethanol, cleared in xylene, and mounted in a Eukitt mounting medium. Images of the whole muscle section were acquired using an Olympus BX51 Microscope. The percentage of NADH-positive areas was measured using ImageJ software (U.S. National Institutes of Health, Bethesda, Maryland, United States of America, <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>).</p>
<p>For sirius red collagen staining, TA sections were fixed 1&#xa0;h with Bouin solution at 56&#xb0;C and stained for 1&#xa0;h with picrosirius red 0.1% (0.1% Direct Red in picric acid), dehydrated in increasing concentrations of ethanol, cleared in xylene, and mounted in a Eukitt mounting medium. Images of the whole muscle section were acquired using an Olympus BX51 Microscope. The percentage of the red area was measured using Fiji software.</p>
<p>For immunofluorescence (IF) staining, TA sections were blocked in PBS containing 0.3% Triton X-100 and 10% NDS for 1&#xa0;h at room temperature (RT) and incubated overnight at 4&#xb0;C with the primary antibody (<xref ref-type="table" rid="T4">Table 4</xref>) in PBS containing 0.3% Triton X-100 and 2% NDS, followed by incubation with the appropriate secondary antibody for 3&#xa0;h at room temperature in the same solution. Immunofluorescence on the TA was visualized at 10X or &#xd7;20 magnification using a Zeiss LSM 800 Confocal Laser Scanning Microscope and processed by ZEN 2.6 (blue edition) (Carl Zeiss, Milan, Italy), taking at least four photos per sample.</p>
<p>The cross-sectional area (CSA) was analyzed using ImageJ Plugin &#x201c;Macro_seg_5_modif.ijm.txt.&#x201d; To evaluate the percentage of positive fibers for MyHC IIa and MyHC IIb, we used Plugin &#x201c;Weka_Segmentation.&#x201d;</p>
<p>The co-localization area of &#x3b1;-bungarotoxin and synaptophysin in NMJs was analyzed using ImageJ (U.S. National Institutes of Health, Bethesda, Maryland, United States of America, <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>).</p>
<p>We used ATPB staining to analyze the mitochondria. The area of the mitochondria in the entire TA was measured using Fiji, while the footprint of mitochondria in the single fibers was processed using Mitochondrial Network Analysis (MiNA), an ImageJ plugin, following the toolset in the work of <xref ref-type="bibr" rid="B39">Valente et al. (2017)</xref>. We chose the fibers with a diameter &#x3c;1000&#xa0;&#x3bc;m (at least three fibers per image); then, the analysis consisted of steps that preserved the quality image, converted it into a binary image, and created a mitochondrial network for the quantitative analysis.</p>
</sec>
<sec id="s2-7">
<title>2.7 Spinal cord and sciatic nerve immunofluorescence and histochemistry</title>
<p>The spinal cords and sciatic nerves of sedentary and trained 91-day-old SOD1-G93A and WT mice (n &#x2265; 5 for each experimental group) were post-fixed in 4% paraformaldehyde, cryoprotected in 30% sucrose in PB, embedded in the O.C.T. compound, and cut using a cryostat at 30&#xa0;&#x3bc;m thickness for the spinal cord (L3&#x2013;L5) and 15&#xa0;&#x3bc;m thickness for the sciatic nerve.</p>
<p>To count the motor neurons, we performed cresyl violet staining (Nissl staining). In brief, the sections were stained with 1% cresyl violet, dehydrated in 50%&#x2013;100% alcohol, cleared in xylene, and mounted in a Eukitt mounting medium (Sigma-Aldrich). The images of the ventral horns were obtained at &#xd7;10 magnification using a Zeiss Axioskop 2 Microscope. The neurons with a cell body area &#x2265;200 &#x3bc;m<sup>2</sup> and a definable cytoplasm with a nucleus and nucleolus were counted using Neurolucida software (MBF Bioscience, United States of America). For immunofluorescence on the spinal cord and sciatic nerve, the sections were blocked for 1&#xa0;h at RT in PBS containing 0.3% Triton X-100 and 10% NDS and incubated for 48&#xa0;h at 4&#xb0;C with the primary antibody (listed in <xref ref-type="table" rid="T4">Table 4</xref>) in PBS containing 0.3% Triton X-100 and 2% NDS, followed by incubation with the appropriate secondary antibody (listed in <xref ref-type="table" rid="T4">Table 4</xref>) for 3&#xa0;h at RT in the same solution, as previously described (<xref ref-type="bibr" rid="B30">Scaricamazza et al., 2022</xref>).</p>
<p>Immunofluorescence on the spinal cord and sciatic nerve sections was visualized at &#xd7;20 magnification using a Zeiss LSM 800 Confocal Laser Scanning Microscope, processed using ZEN 2.6 (blue edition) (Carl Zeiss, Milan, Italy), and analyzed using ImageJ (U. S. National Institutes of Health, Bethesda, Maryland, United States of America, <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>, 1997&#x2013;2016).</p>
</sec>
<sec id="s2-8">
<title>2.8 Data analysis</title>
<p>Data are presented as the mean &#xb1; SEM. For the evaluation of the onset, data were analyzed using the Kaplan&#x2013;Meier curve with a log-rank (Mantel&#x2013;Cox) test and a log-rank test for trend. Then, the non-parametric Mann&#x2013;Whitney test was used to evaluate the difference in the onset between groups (SD G93A and TR G93A). For the analysis of weight, grip strength tests, motor skill tests, histology, and protein and RNA expression, data were evaluated using a two-way ANOVA with the Tukey test as a <italic>post hoc</italic> analysis. Differences between groups were considered significant when the <italic>p</italic>-value was less than 0.05. The normality of the data was assessed using the Shapiro&#x2013;Wilk test. Statistical analysis was carried out using GraphPad Prism 5 software.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Intense endurance exercise brings ALS onset forward</title>
<p>SOD1-G93A and wild-type (WT) female mice underwent an intense endurance exercise protocol on a rodent treadmill for 8&#xa0;weeks, 5&#xa0;days a week, starting at 35 days of age, which is well before any ALS symptoms (<xref ref-type="bibr" rid="B30">Scaricamazza et al., 2022</xref>). To understand the effect of intense endurance exercise on ALS, we analyzed several parameters indicating functional and structural hallmarks of the disease throughout the training. Specifically, we monitored weight, muscle strength, and motor skills and compared them with the sedentary groups.</p>
<p>As shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>, unlike the WT mice that gradually gained weight, the weight of SOD1-G93A mice increased only in the first training weeks. Interestingly, trained SOD1-G93A mice stopped gaining weight earlier than the sedentary mice, at 70 and 77 days of age, respectively (<xref ref-type="fig" rid="F1">Figure 1A</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Intense endurance exercise accelerates the onset of the disease of SOD1-G93A mice. <bold>(A)</bold> Graph representing the weight of sedentary and trained SOD1-G93A mice (SD G93A and TR G93A) and their control littermates (SD WT and TR WT) at the indicated ages and indicated week of training. Data are presented as the means &#xb1; SEM; &#x2a;<italic>p</italic> &#x3c; 0.05 and &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 when compared with SD WT. <bold>(B)</bold> Maximal grip strength of sedentary (SD G93A) and trained (TR G93A) SOD1-G93A mice and their control littermates (SD WT and TR WT) at the indicated ages during the 8 weeks of training. Data are presented as the means &#xb1; SEM; &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 when compared with SD WT. <bold>(C)</bold> Graph representing the evaluation of hind limb extension reflex of trained (TR WT and TR G93A) and sedentary mice (SD WT and SD G93A) at the indicated ages during the training period. Mice were suspended by the tail, and the hind limb posture was evaluated giving scores from 5 (no sign of disease) to 0 (complete impairment). Data are presented as the means &#xb1; SEM; &#x2a;<italic>p</italic> &#x3c; 0.05 and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001 when compared with SD WT. <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 when compared with SD G93A. <bold>(D)</bold> Graph representing the evaluation of gait of trained (TR WT and TR G93A) and sedentary mice (SD WT and SD G93A) at the indicated ages during the training period. Mice movement in an open field was evaluated with a scale from 5 (no sign of disease) to 0 (complete impairment). Data are presented as the means &#xb1; SEM; &#x2a;<italic>p</italic> &#x3c; 0.05 and &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 when compared with SD WT. <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01, <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.001, and <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 when compared with SD G93A. <italic>p</italic>-values in A, B, C, and D were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x3d; 12 per group <bold>(E)</bold> Kaplan&#x2013;Meier graph representing the onset of the disease of the sedentary and trained SOD1-G93A mice (SD G93A and TR G93A) and their control littermates (SD WT and TR WT). <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 compared with SD G93A. <italic>p</italic>-value was obtained by analyzing the mean of the onset of SD G93A and TR G93A with the non-parametric Mann&#x2013;Whitney test.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g001.tif"/>
</fig>
<p>The training improved the muscular strength of WT mice but did not affect the strength of SOD1-G93A mice (<xref ref-type="fig" rid="F1">Figure 1B</xref>). We noticed that the trained transgenic mice tended to be weaker than the sedentary group, even though the difference was not statistically significant (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<p>The training significantly worsened the motor abilities of SOD1-G93A mice. Following the protocol of <xref ref-type="bibr" rid="B24">Milanese et al. (2021)</xref>, we used two different tests to evaluate the motor skills: the hind limb extension reflex and the gait. As shown in <xref ref-type="fig" rid="F1">Figure 1C</xref>, the score of the hind limb extension reflex of trained SOD1-G93A mice started decreasing at 52 days of age, 2&#xa0;weeks before the sedentary transgenic mice. The gait test showed a similar pattern, with the trained transgenic mice starting to lower their score at 59 days of age and the sedentary transgenic mice at 70 days of age (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<p>By taking together the weight, grip strength, and score of the motor skill tests, we defined the onset of the disease (see <xref ref-type="sec" rid="s2">Section 2</xref> for details). As shown in <xref ref-type="fig" rid="F1">Figure 1E</xref>, the training accelerated the onset of the disease by approximately 1&#xa0;week, starting in trained mice at 63 days of age and sedentary mice at 70 days of age.</p>
</sec>
<sec id="s3-2">
<title>3.2 Intense endurance exercise exacerbates the oxidative shift of muscle fibers</title>
<p>Skeletal muscle is a plastic tissue able to change and model its fibers in response to functional and metabolic needs. Intense endurance exercise pushes muscle fibers toward a more oxidative phenotype, promoting the shift from glycolytic to oxidative fibers (<xref ref-type="bibr" rid="B2">Ausoni et al., 1990</xref>; <xref ref-type="bibr" rid="B33">Schiaffino and Reggiani, 2011</xref>; <xref ref-type="bibr" rid="B25">Mukund, 2019</xref>). We have recently demonstrated that the same shift occurs early in the glycolytic skeletal muscles of sedentary SOD1-G93A mice before any denervation events (<xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>). Thus, we wondered if the oxidative status that the training induced caused the early deficit of motor skills in trained SOD1-G93A mice by hastening the damage to skeletal muscles. In detail, we chose to analyze the <italic>tibialis anterior</italic> because it is a glycolytic muscle that we previously characterized and demonstrated to be affected in our model (<xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>; <xref ref-type="bibr" rid="B30">2022</xref>).</p>
<p>To define the oxidative status of the muscle fibers, we performed, at the end of the eighth-week training protocol, an <italic>in situ</italic> NADH-tetrazolium reductase activity assay on the TA muscle of sedentary and trained WT and SOD1-G93A mice (91 days of age). Since the NADH-positive area in the TA of the sedentary SOD1-G93A mice covered almost the entire sample, we could not see any difference between trained and sedentary mice (<xref ref-type="sec" rid="s12">Supplementary Figures S1A, B</xref>). However, we observed an upregulation in the expression levels of sarcolipin (<italic>Sln</italic>) and neuron-derived orphan nuclear receptor (<italic>Nor1</italic>) and a slight downregulation, although not statistically significant, in the expression of glucose transporter type 4 (<italic>Glut4</italic>) in trained SOD1-G93A mice (<xref ref-type="fig" rid="F2">Figure 2A</xref>), indicating that training shifted muscle fibers toward oxidative metabolism.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Intense endurance exercise intensifies the TA oxidative phenotype of SOD1-G93A mice. <bold>(A)</bold> Expression level of mRNA encoding Nor1, Sln, and Glut4 in the TA muscle of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(B)</bold> TA cross sections of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) stained for MyHC IIb and MyHC IIa. Scale bar, 200&#xa0;&#x3bc;m. <bold>(C)</bold> Graphical representation of the percentage of MyHC IIb, MyHC IIa, and MyHC IIx area. MyHC IIx area was assessed measuring the uncolored fibers. Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 00,001. <bold>(D)</bold> Expression level of mRNA encoding MyHC IIa and MyHC IIb in the TA muscle of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05; &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001. <italic>p</italic>-values were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x2265; 5 per group.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g002.tif"/>
</fig>
<p>Consistent with that, immunofluorescence analysis revealed that training led to a significant increase in MyHC IIa/MYH2-positive fibers (<xref ref-type="fig" rid="F2">Figures 2B, C</xref>) and a strong decrease in MyHC IIb/MYH4-positive fibers in SOD1-G93A mice (<xref ref-type="fig" rid="F2">Figures 2B, C</xref>), while it did not affect the MyHC IIx/MYH1-positive area, which was assessed by considering the unstained fibers (<xref ref-type="fig" rid="F2">Figures 2B, C</xref>). According to the literature, MyHC IIb-positive fibers decrease in WT mice after training (<xref ref-type="fig" rid="F2">Figures 2B, C</xref>) (<xref ref-type="bibr" rid="B42">Yan et al., 2011</xref>; <xref ref-type="bibr" rid="B27">Qaisar et al., 2016</xref>). In agreement, we observed the same trend when analyzing the mRNA expression of <italic>Myh2</italic> and <italic>Myh4</italic> in the TA of the same experimental groups (<xref ref-type="fig" rid="F2">Figure 2D</xref>).</p>
<p>The CSA measure corroborated the fiber shift: although the total CSA did not change (<xref ref-type="fig" rid="F3">Figures 3A, B</xref>), by dividing for a specific dimension range and giving 100% to the total number of fibers, we observed that the percentage of small oxidative fibers (&#x3c;1,000&#xa0;&#x3bc;m<sup>2</sup>) increased, while the percentage of large glycolytic fibers (2000&#x2013;3,000&#xa0;&#x3bc;m<sup>2</sup>) decreased if compared to sedentary SOD1-G93A mice (<xref ref-type="fig" rid="F3">Figure 3C</xref>). In agreement with these results, immunofluorescence on the same muscles revealed that training increased the mitochondrial marker ATPB, both in WT and SOD1-G93A mice (<xref ref-type="fig" rid="F3">Figures 3A, D</xref>). Moreover, we detected with the MiNA 2.0 toolset that the oxidative fibers of trained SOD1-G93A mice had larger mitochondrial areas than sedentary WT and SOD1-G93A mice (<xref ref-type="fig" rid="F3">Figures 3E, F</xref>), further confirming oxidative metabolism.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Intense endurance exercise increases mitochondria area in the TA oxidative fibers of SOD1-G93A mice. <bold>(A)</bold> TA cross sections of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) stained for laminin and mitochondrial marker ATPB. Scale bar, 200&#xa0;&#x3bc;m. <bold>(B)</bold> Graphical representation of the total cross-sectional area of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01; &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001. <bold>(C)</bold> Graphical representation of the cross-sectional area of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) divided into groups of sizes ranging from &#x3c;1,000, 1,000&#x2013;2000, and 2000&#x2013;3,000&#xa0;&#x3bc;m<sup>2</sup>. The percentage of the single group of fibers was obtained giving 100% to the total number of fibers. Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(D)</bold> Graphical representation of ATPB area on the TA of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(E)</bold> ATPB staining to detect mitochondria footprint on TA oxidative fibers of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Scale bar, 25&#xa0;&#x3bc;m<sup>2</sup>. Images were obtained with z-stack projection (63x) and next processed using the MiNA toolset. <bold>(F)</bold> Graphical representation of mitochondria footprint obtained in <bold>(E)</bold> and expressed as mitochondrial area &#x3bc;m<sup>2</sup>. Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01. <italic>p</italic>-values were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x2265; 5 per group.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g003.tif"/>
</fig>
<p>Overall, these data suggest that intense endurance training exacerbates the oxidative shift occurring in the glycolytic muscles of SOD1-G93A mice.</p>
</sec>
<sec id="s3-3">
<title>3.3 Intense endurance training speeds up the denervation process in SOD1-G93A mice</title>
<p>Considering that the skeletal muscle of SOD1-G93A mice had a worse oxidative status after training, we next assessed whether intense endurance exercise also affected muscle integrity, particularly fibrosis and denervation.</p>
<p>Picrosirius red staining (<xref ref-type="sec" rid="s12">Supplementary Figures S2A, B</xref>) and collagen type III alpha 1 chain (<italic>Col3a1</italic>) mRNA expression analysis (<xref ref-type="sec" rid="s12">Supplementary Figure S2C</xref>) on the TA of 91-day-old mice showed that training did not affect fibrosis as the percentage of red staining and Col3a1 mRNA expression did not change in sedentary and trained transgenic mice (<xref ref-type="sec" rid="s12">Supplementary Figure S2B</xref>).</p>
<p>On the contrary, denervation strongly advanced in trained SOD1-G93A mice. Specifically, the expression levels of atrophy and denervation markers, such as F-box-only protein 32<bold>/</bold>atrogin-1, acetylcholine receptor &#x3b1; subunit (AChR&#x3b1;), and voltage-gated sodium channel 1.5 (Na<sub>v</sub>1.5), increased in SOD1-G93A mice after training compared to the sedentary mice (<xref ref-type="fig" rid="F4">Figure 4A</xref>). To further investigate the denervation process, we evaluated the neuromuscular junction (NMJ) dismantling in the TA of trained transgenic mice. Comparing trained and sedentary transgenic mice, immunofluorescence analysis showed a reduced co-localization of nicotinic acetylcholine receptor (nAChR) clusters (defined with &#x3b1;-bungarotoxin, &#x3b1;-BTXN) and synaptophysin (SYN) in trained mice, indicating increased NMJ instability (<xref ref-type="fig" rid="F4">Figures 4B, C</xref>). Dystrophin (Dys) and low-density lipoprotein receptor-related protein 4 (LRP4) are essential for NMJ stability and postsynaptic differentiation, and, as we previously reported, they increase in SOD1-G93A mice starting at 120 days of age (<xref ref-type="bibr" rid="B30">Scaricamazza et al., 2022</xref>), probably to counter the damage of denervation. As shown in <xref ref-type="fig" rid="F4">Figures 4D&#x2013;F</xref>, training accelerated the upregulation of LRP4 and Dys in SOD1-G93A mice, further confirming the reduced NMJ stability.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Intense endurance exercise promotes denervation in skeletal muscle of SOD1-G93A mice. <bold>(A)</bold> Expression level of mRNA encoding atrogin-1, AchR&#x3b1;, and Na<sub>V</sub>1.5 on the TA of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(B)</bold> TA cross sections of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) staining for &#x3b1;-bungarotoxin (&#x3b1;-BTXN) and synaptophysin (SYN) to detect NMJ (scare bar: 20&#xa0;&#x3bc;m). <bold>(C)</bold> Graphical representation of &#x3b1;-BTXN and SYN co-localization percentage. Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. Representative Western blots <bold>(D)</bold> and quantification of <bold>(E)</bold> dystrophin (Dys) and <bold>(F)</bold> lipoprotein receptor-related protein 4 (LRP4) on TA of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01; &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001. <italic>p</italic>-values were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x2265; 5 per group.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Intense endurance exercise enhanced Wallerian degeneration in the peripheral nervous system of SOD1-G93A mice</title>
<p>We assessed whether intense endurance exercise had an impact on demyelination, axonal loss, and inflammation in the peripheral nervous system. To this end, cross sections of the sciatic nerves of 91-day-old sedentary and trained WT and SOD1-G93A mice were probed with antibodies recognizing myelin basic protein (MBP), neurofilament heavy chain (NFH), and pro-inflammatory immune cells (CD68). As shown in <xref ref-type="fig" rid="F5">Figure 5</xref>, training enhanced Wallerian degeneration in SOD1-G93A mice by prompting myelin degradation and loss of the axonal cytoskeleton, as indicated by the reduction in MBP and NFH expression levels, respectively (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>). The damage in the sciatic nerve came with immune cell infiltration, as the stronger staining of CD68 in the sections of trained SOD1-G93A mice revealed in <xref ref-type="fig" rid="F5">Figures 5A, D</xref>.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Intense endurance exercise accelerates Wallerian degeneration in the sciatic nerve of SOD1-G93A mice. <bold>(A)</bold> Sciatic nerve cross sections of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) staining for myelin (MBP), neurofilament heavy (NFH), and activated immune cells (CD68). Scale bar, 50&#xa0;&#x3bc;m. Graphical representation of MBP <bold>(B)</bold>, NFH <bold>(C),</bold> and CD68 <bold>(D)</bold> expression. Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001. <bold>(E)</bold> Sciatic nerve cross sections of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A) staining for phagocytic GFAP &#x2b; Schwan cells (GFAP) and graphical representation <bold>(F)</bold>. Scale bar, 50&#xa0;&#x3bc;m. Data are presented as the means &#xb1; SEM. &#x2a;<italic>p</italic> &#x3c; 0.05; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <italic>p</italic>-values were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x2265; 5 per group.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g005.tif"/>
</fig>
<p>Further confirming demyelination, sciatic nerve cross sections of trained transgenic mice showed increased staining of glial fibrillary acidic protein (GFAP) (<xref ref-type="fig" rid="F5">Figures 5E, F</xref>), usually expressed in non-myelinating Schwann cells (<xref ref-type="bibr" rid="B43">Yang and Wang, 2015</xref>).</p>
</sec>
<sec id="s3-5">
<title>3.5 Intense endurance training accelerates motor neuron loss and neuroinflammation in SOD1-G93A mice</title>
<p>Motor neuron loss is the final stage and the most characteristic hallmark of ALS. To determine if intense endurance exercise affected motor neurons, we performed Nissl staining on cross sections of the lumbar spinal cord (L3&#x2013;L5) of sedentary and trained WT and SOD1-G93A mice. As shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, 91-day-old sedentary SOD1-G93A mice had a reduction of approximately 20% in the percentage of ventral horn motor neurons compared with the sedentary WT mice (<xref ref-type="fig" rid="F6">Figures 6A, B</xref>). Interestingly, after training, SOD1-G93A mice reached a 50% reduction (<xref ref-type="fig" rid="F6">Figures 6A, B</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Intense endurance exercise worsens motor neuron loss and neuroinflammation in the spinal cord of SOD1-G93A mice. <bold>(A)</bold> Representative lumbar spinal cord sections (L3&#x2013;L5) stained with cresyl violet (scale bar, 100&#xa0;&#x3bc;m) and <bold>(B)</bold> graphical quantification of the motor neuron number percentage of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(C)</bold> Representative immunofluorescence images (scale bar, 100&#xa0;&#x3bc;m); graphical representation of <bold>(D)</bold> activated astrocytes (GFAP) and <bold>(E)</bold> activated microglia (CD68) in the lumbar spinal cord sections (L3&#x2013;L5) of 91-day-old sedentary and trained wild-type and SOD1-G93A mice (SD WT, TR WT, SD G93A, and TR G93A). Data are presented as the means &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <italic>p</italic> values were obtained using parametric two-way ANOVA with a Tukey <italic>post hoc</italic> test. n &#x2265; 5 per group.</p>
</caption>
<graphic xlink:href="fphar-15-1360099-g006.tif"/>
</fig>
<p>In ALS, the death of motor neurons comes with a neuroinflammatory response characterized by the activation of reactive microglia and astrocytes (<xref ref-type="bibr" rid="B41">Volont&#xe9; et al., 2019</xref>). Here, the identification of microglial and astrocytic markers by immunofluorescence (CD68 and GFAP, respectively) showed that these two cell populations were more active in trained SOD1-G93A mice than in sedentary controls (<xref ref-type="fig" rid="F6">Figures 6C&#x2013;E</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>The benefits of PA on fitness and mental health have been widely described. Indeed, by acting on specific mechanisms, PA can influence the physiology of several chronic conditions. Skeletal muscle metabolism and regeneration, neurogenesis, mitochondrial biogenesis, and antioxidant defense are only some of the pathways that PA improves, and interestingly, they are all involved in ALS pathology (<xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>). The relationship between PA and ALS is still under debate (<xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>; <xref ref-type="bibr" rid="B5">Chapman et al., 2023</xref>), as clinical and preclinical studies have so far led to contradictory findings, probably because of the heterogeneity of ALS (sporadic and familial) and the different types (i.e., running; swimming, and cycling) and intensities (high, moderate, or low) of PA analyzed (<xref ref-type="bibr" rid="B38">Tsitkanou et al., 2019</xref>; <xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>). Moreover, most studies did not distinguish between aerobic and anaerobic activities, a shortcoming that is likely responsible for the different conclusions (<xref ref-type="bibr" rid="B5">Chapman et al., 2023</xref>).</p>
<p>Regardless of the type, only the intensity of the exercise seems to affect the onset and progression of ALS (<xref ref-type="bibr" rid="B31">Scaricamazza et al., 2021</xref>). Indeed, high-intensity PA carried out during leisure time correlates with an early onset of the disease in ALS patients (<xref ref-type="bibr" rid="B15">Huisman et al., 2013</xref>). This evidence is corroborated by a cross-sectional study that reported a significant increase in patients diagnosed with early ALS among those who had a history of vigorous leisure PA during early adulthood (<xref ref-type="bibr" rid="B28">Raymond et al., 2021</xref>); finally, strenuous PA seems to increase the penetrance of ALS in patients with a risk genotype, predisposing particularly those with C9ORF72 expansion to present a higher risk for PA-aggravated disease (<xref ref-type="bibr" rid="B16">Julian et al., 2021</xref>).</p>
<p>We designed our study (an endurance training inducing oxidative metabolism in SOD1-G93A female mice) to be comparable to high-intensity PA performed during leisure time far from the onset of the disease. We highlighted how endurance training significantly accelerated the onset, worsening the progression of the disease in SOD1-G93A mice.</p>
<p>Accordingly, <xref ref-type="bibr" rid="B13">Golini et al. (2023)</xref> recently reported that repeated voluntary running on home-cage running-wheel systems negatively affects disease progression by anticipating disease onset in SOD1-G93A low-copy male mice. Partially in conflict, Mahoney and others did not observe any impact of endurance training on the disease onset of SOD1-G93A mice. However, the training protocol and method used to detect the onset are different compared to ours. Nevertheless, extending their study until the death of the animals, <xref ref-type="bibr" rid="B21">Mahoney et al. (2004)</xref> demonstrated that intense endurance exercise worsened motor performance after the clinical onset and hastened death in male mice without any significant effects in female mice. Here, we examined female mice, and although it is widely described that this biological sex has better outcomes compared to male mice in terms of pathology (<xref ref-type="bibr" rid="B14">Heiman-Patterson et al., 2005</xref>; <xref ref-type="bibr" rid="B3">Cacabelos et al., 2016</xref>), our training paradigm was able to accelerate the symptoms, exacerbating the hallmarks of the disease.</p>
<p>In our study, we pinpointed the onset of the disease by examining both neuromotor functions and functional skills. In particular, the analysis of the motor skills indicated that the decline in performance was faster in trained SOD1-G93A mice than in transgenic sedentary mice. Noteworthy, the performance worsened between the third and fourth weeks of training, when the exercise protocol had not yet reached the maximum levels of duration, speed, and slope. Unexpectedly, we did not observe differences in the decline of muscle strength between trained and sedentary SOD1-G93A mice, leading us to hypothesize the presence of a compensatory mechanism. Trained WT and SOD1-G93A mice exhibited a higher expression of the mitochondrial complex V subunit ATPB in the TA and a larger mitochondrial area in muscle fibers, and basically, the biogenesis of mitochondria and their content is linked to muscular strength (<xref ref-type="bibr" rid="B19">Lundby and Jacobs, 2016</xref>; <xref ref-type="bibr" rid="B20">MacInnis and Gibala, 2017</xref>; <xref ref-type="bibr" rid="B7">Distefano and Goodpaster, 2018</xref>).</p>
<p>In line with the early onset, the disease progressed faster in trained transgenic animals, as confirmed by the immunopathological and molecular analyses carried out at the end of training (91 days of age). Our results revealed massive NMJ dismantling and loss of motor neurons in the spinal cord, suggesting that training brought forward the pathological stage by approximately 30 days since 91-day-old trained SOD1-G93A mice resembled the phenotype of 120-day-old sedentary SOD1-G93A mice (<xref ref-type="bibr" rid="B32">Scaricamazza et al., 2020</xref>). In contrast to our finding, <xref ref-type="bibr" rid="B4">Carreras et al. (2010)</xref> concluded that intense endurance training did not worsen motor neuron loss in SOD1-G93A mice; however, their training protocol (number of training days, time, speed, and slope) was milder than ours. Noteworthy, it has been demonstrated that moderate-intensity aerobic exercise protected ALS-SOD1 mice from motor neuron loss, delaying the onset of motor symptoms and extending lifespan (<xref ref-type="bibr" rid="B18">Kirkinezos et al., 2003</xref>; <xref ref-type="bibr" rid="B4">Carreras et al., 2010</xref>). Furthermore, <xref ref-type="bibr" rid="B12">Ferri et al. (2019)</xref> reported that moderate-intensity aerobic exercise has a beneficial effect on ALS patients, improving their aerobic fitness and maintaining their physical functions.</p>
<p>We saw that the neuromuscular damage in SOD1-G93A mice, induced by training and characterized by NMJ dismantling and spinal motor neuron loss, came with neuroinflammation in both peripheral and central nervous systems. Moreover, we detected increased Wallerian degeneration with the infiltration of macrophages in the sciatic nerve and the activation of microglia and astrocytes in the spinal cord. Similarly, <xref ref-type="bibr" rid="B17">Kassa et al. (2017)</xref>, using a milder protocol of endurance training, observed enhanced microglia activation in SOD1-G93A mice, even though the number of motor neurons and the onset of the disease were comparable to the sedentary controls.</p>
<p>Recent findings have highlighted the fact that exercise has anti-inflammatory effects on the whole body. In the nervous system, exercise prevents neuroinflammation by increasing the expression of neurotrophic factors and anti-inflammatory cytokines while reducing the levels of pro-inflammatory cytokines and activated microglia (<xref ref-type="bibr" rid="B23">Mee-Inta et al., 2019</xref>; <xref ref-type="bibr" rid="B34">Seo et al., 2019</xref>). Accordingly, in certain brain diseases, such as Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and Huntington&#x2019;s disease, exercise reduces neuroinflammation and improves prognosis (<xref ref-type="bibr" rid="B37">Svensson et al., 2015</xref>; <xref ref-type="bibr" rid="B35">Spielman et al., 2016</xref>; <xref ref-type="bibr" rid="B34">Seo et al., 2019</xref>). The studies have pointed out how the intensity of the exercise is crucial for neuroprotection (<xref ref-type="bibr" rid="B44">Zaychik et al., 2021</xref>). For instance, in a mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis mice), high-intensity and regular training reduces autoimmune neuroinflammation by decreasing pro-inflammatory cytokines and microglial-derived ROS (<xref ref-type="bibr" rid="B29">Rizzo et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Zaychik et al., 2021</xref>).</p>
<p>In light of these studies, it is imperative to highlight the controversial nature of ALS data, further considering that many studies, including this one, are based on preclinical models. Nevertheless, it is worth pointing out that while a physically active lifestyle is generally associated with a lower risk of brain diseases, addressing the role of PA in ALS requires closer scrutiny.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>In SOD1-G93A mice, intense endurance exercise, administered before the onset of any ALS symptoms, anticipates the disease onset and worsens symptom progression by accelerating the pathological phenotype, suggesting that PA represents a risk factor in ALS. Moreover, intense endurance exercise in SOD1-G93A mice affects the entire skeletal muscle-motor neuron axis. This exercise protocol alters the muscular component by increasing the metabolic shift, induces the dismantling of the NMJ, generates inflammation in the peripheral nerve by altering its morphology, and increases the loss of motor neurons from the spinal cord ventral horns. In the present study, we also corroborated the theory about the important role of the interplay between skeletal muscle and motor neurons in the development of ALS disease. The so-called &#x201c;dying-back hypothesis&#x201d; proposes that a retrograde signaling cascade contributes to motor neuron degeneration. Here, we demonstrated that exacerbated damage to skeletal muscle through intense endurance exercise speeds up the denervation process and, thus, motor neuron loss. Although the intervention we proposed had a detrimental effect, it also suggests the pivotal role of skeletal muscle as a target in therapeutic strategies. Indeed, an intervention aimed at addressing the decline in muscle health has the potential to counteract the dying-back process and provide a protective shield for motor neurons. The physiological characteristics and accessibility of muscle tissue further enhance its appeal as a therapeutic target.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by the Direzione Generale della Sanit&#xe0; Animale e dei Farmaci veterinari (DGSAF) Ufficio 6&#x2014;Tutela del benessere animale, igiene zootecnica e igiene urbana veterinaria. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>SS: conceptualization, data curation, formal analysis, investigation, methodology, writing&#x2013;review and editing, and validation. VN: conceptualization, data curation, formal analysis, investigation, methodology, writing&#x2013;review and editing, and validation. IS: writing&#x2013;review and editing, data curation, investigation, methodology, and validation. GF: data curation, investigation, methodology, validation, and writing&#x2013;review and editing. MR: data curation, funding acquisition, investigation, validation, visualization, and writing&#x2013;review and editing. MG: investigation, validation, and writing&#x2013;review and editing. MP: conceptualization, visualization, and writing&#x2013;review and editing. LM: funding acquisition, validation, visualization, and writing&#x2013;review and editing. AF: conceptualization, data curation, funding acquisition, investigation, supervision, validation, visualization, and writing&#x2013;original draft. CV: conceptualization, data curation, investigation, supervision, validation, visualization, and writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The authors declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by &#x201c;CNR IFT DBA.AD005.225-NUTRAGE-FOE 2021,&#x201d; Italian Ministry of Health RF-2019-12369105 to AF, AFM Telethon grant no. 24349, AIRC-MFAG 2022 no. 27578 to LM, and Italian Ministry of Health SG-2019_12368589 to MR.</p>
</sec>
<ack>
<p>This work is dedicated to the memory of the authors&#x2019; mentor and friend Maria Teresa Carr&#xec;.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2024.1360099/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2024.1360099/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alizadeh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Daryanoosh</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moatari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoseinzadeh</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effects of aerobic and anaerobic training programs together with omega-3 supplement on interleukin-17 and CRP plasma levels in male mice</article-title>. <source>Med. J. Islam Repub. Iran.</source> <volume>29</volume>, <fpage>236</fpage>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ausoni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gorza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schiaffino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lomo</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Expression of myosin heavy chain isoforms in stimulated fast and slow rat muscles</article-title>. <source>J. Neurosci.</source> <volume>10</volume>, <fpage>153</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.10-01-00153.1990</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cacabelos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ram&#xed;rez-N&#xfa;&#xf1;ez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Granado-Serrano</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ayala</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moiseeva</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS</article-title>. <source>Acta Neuropathol. Commun.</source> <volume>4</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/S40478-015-0271-6</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carreras</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yuruker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aytan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>B. G.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Moderate exercise delays the motor performance decline in a transgenic model of ALS</article-title>. <source>Brain Res.</source> <volume>1313</volume>, <fpage>192</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.11.051</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cooper-Knock</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence</article-title>. <source>Brain</source> <volume>146</volume>, <fpage>1745</fpage>&#x2013;<lpage>1757</lpage>. <pub-id pub-id-type="doi">10.1093/BRAIN/AWAC470</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dasso</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>How is exercise different from physical activity? A concept analysis</article-title>. <source>Nurs. Forum (Auckl)</source> <volume>54</volume>, <fpage>45</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1111/NUF.12296</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Distefano</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Goodpaster</surname>
<given-names>B. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Effects of exercise and aging on skeletal muscle</article-title>. <source>Cold Spring Harb. Perspect. Med.</source> <volume>8</volume>, <fpage>a029785</fpage>. <pub-id pub-id-type="doi">10.1101/CSHPERSPECT.A029785</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupuis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Echaniz-Laguna</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments</article-title>. <source>Curr. Drug Targets</source> <volume>11</volume>, <fpage>1250</fpage>&#x2013;<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.2174/1389450111007011250</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupuis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gonzalez de Aguilar</surname>
<given-names>J.-L.</given-names>
</name>
<name>
<surname>Oudart</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>de Tapia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barbeito</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Loeffler</surname>
<given-names>J.-P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Mitochondria in amyotrophic lateral sclerosis: a trigger and a target</article-title>. <source>Neurodegener. Dis.</source> <volume>1</volume>, <fpage>245</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1159/000085063</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupuis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pradat</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Ludolph</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Loeffler</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Energy metabolism in amyotrophic lateral sclerosis</article-title>. <source>Lancet Neurol.</source> <volume>10</volume>, <fpage>75</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70224-6</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coccurello</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>What is &#x201c;hyper&#x201d; in the ALS hypermetabolism?</article-title> <source>Mediat. Inflamm.</source> <volume>2017</volume>, <fpage>7821672</fpage>. <pub-id pub-id-type="doi">10.1155/2017/7821672</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lanfranconi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Corna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bonazzi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marchese</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Magnoni</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Tailored exercise training counteracts muscle disuse and attenuates reductions in physical function in individuals with amyotrophic lateral sclerosis</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <fpage>1537</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.01537</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Marinelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pisu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Angelis</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vacca</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rava</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Wheel running adversely affects disease onset and neuromuscular interplay in amyotrophic lateral sclerosis slow progression mouse model</article-title>. <source>Curr. Neurovasc Res.</source> <volume>20</volume>, <fpage>362</fpage>&#x2013;<lpage>376</lpage>. <pub-id pub-id-type="doi">10.2174/1567202620666230823095922</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heiman-Patterson</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Deitch</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Blankenhorn</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Perreault</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>B. K.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS</article-title>. <source>J. Neurol. Sci.</source> <volume>236</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2005.02.006</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huisman</surname>
<given-names>M. H. B.</given-names>
</name>
<name>
<surname>Seelen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Dorresteijn</surname>
<given-names>K. R. I. S.</given-names>
</name>
<name>
<surname>Van Doormaal</surname>
<given-names>P. T. C.</given-names>
</name>
<name>
<surname>Van Der Kooi</surname>
<given-names>A. J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Lifetime physical activity and the risk of amyotrophic lateral sclerosis</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>84</volume>, <fpage>976</fpage>&#x2013;<lpage>981</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-304724</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julian</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Glascow</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>A. D. F.</given-names>
</name>
<name>
<surname>Moll</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Klimentidis</surname>
<given-names>Y. C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes</article-title>. <source>EBioMedicine</source> <volume>68</volume>, <fpage>103397</fpage>. <pub-id pub-id-type="doi">10.1016/J.EBIOM.2021.103397</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kassa</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Bonafede</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Boschi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bentivoglio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Effect of physical exercise and anabolic steroid treatment on spinal motoneurons and surrounding glia of wild-type and ALS mice</article-title>. <source>Brain Res.</source> <volume>1657</volume>, <fpage>269</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/J.BRAINRES.2016.12.029</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkinezos</surname>
<given-names>I. G.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C. T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis</article-title>. <source>Ann. Neurol.</source> <volume>53</volume>, <fpage>804</fpage>&#x2013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10597</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundby</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Adaptations of skeletal muscle mitochondria to exercise training</article-title>. <source>Exp. Physiol.</source> <volume>101</volume>, <fpage>17</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1113/EP085319</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacInnis</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Gibala</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Physiological adaptations to interval training and the role of exercise intensity</article-title>. <source>J. Physiol.</source> <volume>595</volume>, <fpage>2915</fpage>&#x2013;<lpage>2930</lpage>. <pub-id pub-id-type="doi">10.1113/JP273196</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahoney</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Devries</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tarnopolsky</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis</article-title>. <source>Muscle Nerve</source> <volume>29</volume>, <fpage>656</fpage>&#x2013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1002/mus.20004</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mead</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reiser</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>22</volume>, <fpage>185</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-022-00612-2</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mee-Inta</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z. W.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>Y. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Physical exercise inhibits inflammation and microglial activation</article-title>. <source>Cells</source> <volume>8</volume>, <fpage>691</fpage>. <pub-id pub-id-type="doi">10.3390/CELLS8070691</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milanese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bonifacino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Torazza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Provenzano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ravera</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis</article-title>. <source>Br. J. Pharmacol.</source> <volume>178</volume>, <fpage>3747</fpage>&#x2013;<lpage>3764</lpage>. <pub-id pub-id-type="doi">10.1111/BPH.15515</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mukund</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>Skeletal muscle: a review of molecular structure and function</article-title>,&#x201d; in <source>Health and disease</source>, <fpage>1</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/wsbm.1462</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peggion</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Massimino</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Biancotto</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Angeletti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reggiani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sorgato</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>409</volume>, <fpage>2143</fpage>&#x2013;<lpage>2153</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-016-0160-2</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaisar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhaskaran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Van Remmen</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Muscle fiber type diversification during exercise and regeneration</article-title>. <source>Free Radic. Biol. Med.</source> <volume>98</volume>, <fpage>56</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/J.FREERADBIOMED.2016.03.025</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Factor-Litvak</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Horton</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010&#x2013;2018</article-title>. <source>Amyotroph. Lateral Scler. Front. Degener.</source> <volume>22</volume>, <fpage>535</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1080/21678421.2021.1910308</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzo</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Guadalupi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sanna</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vanni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fresegna</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Vito</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis</article-title>. <source>Brain Behav. Immun.</source> <volume>98</volume>, <fpage>13</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/J.BBI.2021.08.212</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scaricamazza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salvatori</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Amadio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nesci</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Torcinaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giacovazzo</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Repurposing of Trimetazidine for amyotrophic lateral sclerosis: a study in SOD1G93A mice</article-title>. <source>Br. J. Pharmacol.</source> <volume>179</volume>, <fpage>1732</fpage>&#x2013;<lpage>1752</lpage>. <pub-id pub-id-type="doi">10.1111/BPH.15738</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scaricamazza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salvatori</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ferri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Skeletal muscle in ALS: an unappreciated therapeutic opportunity?</article-title> <source>Cells</source> <volume>10</volume>, <fpage>525</fpage>&#x2013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.3390/CELLS10030525</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scaricamazza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salvatori</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Giacovazzo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Loeffler</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Ren&#xe8;</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rosina</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Skeletal-muscle metabolic reprogramming in ALS-SOD1 G93A mice predates disease onset and is A promising therapeutic target</article-title>. <source>iScience</source> <volume>23</volume>, <fpage>101087</fpage>. <pub-id pub-id-type="doi">10.1016/J.ISCI.2020.101087</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiaffino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reggiani</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Fiber types in Mammalian skeletal muscles</article-title>. <source>Physiol. Rev.</source> <volume>91</volume>, <fpage>1447</fpage>&#x2013;<lpage>1531</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00031.2010</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Heo</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>H. B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Exercise and neuroinflammation in health and disease</article-title>. <source>Int. Neurourol. J.</source> <volume>23</volume>, <fpage>S82</fpage>&#x2013;<lpage>S92</lpage>. <pub-id pub-id-type="doi">10.5213/INJ.1938214.107</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spielman</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Klegeris</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Physical activity and exercise attenuate neuroinflammation in neurological diseases</article-title>. <source>Brain Res. Bull.</source> <volume>125</volume>, <fpage>19</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/J.BRAINRESBULL.2016.03.012</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steyn</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Ioannides</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Van Eijk</surname>
<given-names>R. P. A.</given-names>
</name>
<name>
<surname>Heggie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Ceslis</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Hypermetabolism in ALS is associated with greater functional decline and shorter survival</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>89</volume>, <fpage>1016</fpage>&#x2013;<lpage>1023</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2017-317887</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Svensson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lexell</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deierborg</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings</article-title>. <source>Neurorehabil Neural Repair</source> <volume>29</volume>, <fpage>577</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1177/1545968314562108</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsitkanou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gatta</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Foletta</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The role of exercise as a non-pharmacological therapeutic approach for amyotrophic lateral sclerosis: beneficial or detrimental?</article-title> <source>Front. Neurol.</source> <volume>10</volume>, <fpage>783</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2019.00783</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valente</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Maddalena</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture</article-title>. <source>Acta histochem.</source> <volume>119</volume>, <fpage>315</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/J.ACTHIS.2017.03.001</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veldink</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>B&#xe4;r</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Joosten</surname>
<given-names>E. A. J.</given-names>
</name>
<name>
<surname>Otten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wokke</surname>
<given-names>J. H. J.</given-names>
</name>
<name>
<surname>Van Den Berg</surname>
<given-names>L. H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Sexual differences in onset of disease and response to exercise in a transgenic model of ALS</article-title>. <source>Neuromuscul. Disord.</source> <volume>13</volume>, <fpage>737</fpage>&#x2013;<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-8966(03)00104-4</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volont&#xe9;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Amadio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fabbrizio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Apolloni</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Functional microglia neurotransmitters in amyotrophic lateral sclerosis</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>94</volume>, <fpage>121</fpage>&#x2013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2019.04.014</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Okutsu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Lira</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle</article-title>. <source>J. Appl. Physiol.</source> <volume>110</volume> (<issue>1985</issue>), <fpage>264</fpage>&#x2013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1152/JAPPLPHYSIOL.00993.2010</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K. K. W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker</article-title>. <source>Trends Neurosci.</source> <volume>38</volume>, <fpage>364</fpage>&#x2013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2015.04.003</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaychik</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fainstein</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Touloumi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hamdi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>High-intensity exercise training protects the brain against autoimmune neuroinflammation: regulation of microglial redox and pro-inflammatory functions</article-title>. <source>Front. Cell Neurosci.</source> <volume>15</volume>, <fpage>640724</fpage>. <pub-id pub-id-type="doi">10.3389/FNCEL.2021.640724</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>